Believes UK is at a 'tipping point'
To begin in June 2018
Concerned about weaker economic figures
Talks started on Monday
Amid rising debt and weak economic data
Third consecutive hike
A Q&A with BB Biotech's Head of Investment Management Daniel Koller reveals how innovation in medicine is offering investment opportunities.